A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia.

  • 1 February 1989
    • journal article
    • clinical trial
    • Vol. 16, 21-4
Abstract
No abstract available

This publication has 0 references indexed in Scilit: